Century Therapeutics
IPSC
IPSC
50 hedge funds and large institutions have $335M invested in Century Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 8 closing their positions.
Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
22
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Marshall Wace
London,
United Kingdom
|
$11.1M |
| 2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$6.52M |
| 3 |
3
BlackRock
New York
|
$13.1M |
| 4 |
4
Morgan Stanley
New York
|
$7.08M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$8.69M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Millennium Management
New York
| – | -$1.74M | -69,024 | Closed |
|
|
CCM
52
CAAS Capital Management
New York
| – | -$755K | -30,000 | Closed |
|
53
Citadel Advisors
Miami,
Florida
| – | -$605K | -24,044 | Closed |
|
|
GCM
54
Ghisallo Capital Management
Boston,
Massachusetts
| – | -$377K | -15,000 | Closed |
|
55
RhumbLine Advisers
Boston,
Massachusetts
| – | -$219K | -8,697 | Closed |
|
56
SG Americas Securities
New York
| – | -$134K | -5,314 | Closed |
|
|
MIM
57
MetLife Investment Management
Whippany,
New Jersey
| – | -$124K | -4,939 | Closed |
|
|
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$94K | -3,737 | Closed |
|